#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myeloid leukaemia Thrombotic thrombocytopenic purpura Lip and/or oral cavity cancer Deafness bilateral Mantle cell lymphoma Thymic carcinoma High-grade B-cell lymphoma Dermatitis Red blood cell abnormality Immune-mediated enterocolitis Small cell lung cancer recurrent Gaucher's disease type III Becker's muscular dystrophy Cushing's syndrome Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Life with Disease Stevens-Johnson syndrome – Diagnostics Ewing’s sarcoma metastatic – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Treatment Nephroblastoma – Trials in Disease Splenic marginal zone lymphoma – Life with Disease Angiosarcoma recurrent – Life with Disease Marginal zone lymphoma – Diagnostics Metachromatic leukodystrophy – Trials in Disease Haemophilia B with anti factor IX – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Acenocoumarol Zanidatamab Repotrectinib Levetiracetam Rbl007.2 Isoleucine Imlifidase Mva-209-Fsp-B2 Bi 765845 Sym024 Estradiol Hemihydrate Abemaciclib Tigulixostat Crisantaspase Ursodeoxycholic Acid Pyridoxine Hydrochloride Naloxone Dinoprostone Phenylephrine Clazakizumab More therapies…

    Learn about Your Condition

    Periarthritis Corneal dystrophy Biliary adenoma Cerebrovascular accident Peritoneal cancer index Aicardi-Goutieres syndrome Epithelioid sarcoma Aortic stenosis Delirium Laryngeal leukoplakia Paraesthesia Encephalopathy neonatal Hypomagnesaemia Liposarcoma recurrent Pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adenocarcinoma of colon

  • Study on Atezolizumab with FOLFOX for Stage III Colon Cancer with Deficient DNA Mismatch Repair

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    • Colon cancer stage III
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Atezolizumab
    • Fluorouracil
    Germany

  • Study on Temozolomide and Irinotecan for Patients with Stage II/III Colorectal Cancer and Positive ctDNA After Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Temozolomide
    • Irinotecan Hydrochloride
    Italy

  • Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Dostarlimab
    • Capecitabine
    • Fluorouracil
    Belgium Czechia Estonia Finland France Germany +8

  • Study on FOLFOX Chemotherapy for Treating Advanced Colon Cancer in Patients Aged 70 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    • Colorectal adenocarcinoma
    • DNA mismatch repair protein gene mutation
    Investigated Drugs:
    • Mycobaterium Obuense, Strain Nctc 13365, Heat-Killed
    • Atezolizumab
    Germany

  • Study on Holmium-166 TARE and Maintenance Therapy with Capecitabine, Bevacizumab, and Drug Combination for Patients with Unresectable Liver-Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Panitumumab
    • Bevacizumab
    • Calcium Folinate
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!